Description

Reopoligliucin (Dextran 40, Sodium Chloride) Solution for Infusions 200 ml Vial

Ingredients

Reopoligliucin solution for infusions contains dextran 40 and sodium chloride as active ingredients.

Dosage

The dosage of Reopoligliucin should be determined by a healthcare professional based on the patient’s condition and needs.

Indications

Reopoligliucin is indicated for use in conditions where plasma volume expansion is required.

Contraindications

Do not use Reopoligliucin if the patient has a known hypersensitivity to any of the ingredients.

Directions

Reopoligliucin should be administered intravenously by a healthcare professional following proper dilution and infusion rates.

Scientific Evidence

Studies have shown the efficacy of dextran solutions like Reopoligliucin in increasing plasma volume and improving hemodynamic stability in various clinical settings.

Additional Information

It is important to monitor the patient for signs of fluid overload or hypersensitivity reactions during Reopoligliucin infusion.

Pharmacological Effects: Reopoligliucin works by expanding plasma volume, which can help improve tissue perfusion and oxygen delivery in conditions such as hypovolemia or shock.

Clinical Trials: Clinical trials have demonstrated the effectiveness of dextran solutions in improving outcomes in patients with hypovolemic shock and sepsis, highlighting the importance of plasma volume expansion in critical care settings.